Reading IVZ? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IVZ free→
IVZ
InvescoNYSEFinancialsAsset ManagementSnapshot 2026-06-12
Watch· 1–3 mo
$28.92+2.23%
Close 2026-06-12 · 1-day change
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
The bottom line
Recent financial performance is weak, and earnings quality cannot be assessed since the company was unprofitable over the past year. Risk is moderate, and the sector backdrop is a headwind, which may impact future performance. Peer multiples imply a price about 23% above where it trades (it looks cheap on this basis); the read is fair, but weakening. Key factors to watch include any potential guidance cuts and the performance of sector bellwethers like BLK, BX, and KKR. This read is provisional.
as of 2026-06-12
Quick facts
- Exchange
- NYSE
- Sector
- Financials
- Industry
- Asset Management
- Market cap
- $12.37B
- Employees
- 7,499
- IPO date
- 1999-03-31
- Next earnings
- 2026-07-28
Price
Daily closes. Earnings/event dots are placed inline.
Adjusted daily closes (split & dividend). Scroll over the chart to zoom; click a range to reset.
EarningsMaterial event
What's priced in
(what the market already expects)What it's worth (estimated)
A consensus fair price across 8 valuation methods, at three horizons. Current price $28.92. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
12-month· primaryfair
$37.46consensus
Range $26.57 – $50.19
vs price: -23% below
Method agreement — · 8 methods
No-growth: today's peer multiple on trailing earnings. The headline read.
3-yearinexpensive
$72.53consensus
Range $48.88 – $86.16
vs price: -60% below
Method agreement — · 7 methods
Embeds projected growth. Leans optimistic by design. Upside context.
5-yearinexpensive
How much to trust our fair value
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
Aligned with peerslow confidence
At $29 IVZ trades at 16× p/e, in line with its 15× p/e peer median. Our $37 fair value reflects that, low confidence. Analysts: $26–$31. Not investment advice.
Multiple (P/E)
16.3x
peer 14.9x · own history 10.8x
Premium
1.1x peer
1.5x its own history
Growth the price needs
-23%
our forecast 4%
Our fair value
$37.39
range $26.57 – $50.27
Analyst range(a guide on our number, not a target)Our number is above the analyst range
How this stock is priced
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Long-term · 1–3 yr
fairfair — but weakening12-month view
What's priced inJustified
The price implies about 23% below a flat-multiple fair value, below our forecast of about 4%. This describes what's priced in, not a forecast of the move.
Low fragilityrisk posture, not a price call
Only a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
Historical context
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
How strong is the business
(quality & execution)Factor signals
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Recent financial performance
weakOperating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Financials names rated weak grew net income 56% of the time over the next year (vs 59% for the rest of the cohort, n=3730).
7th pctl · Financials
Earnings quality
loss makingOver the trailing year it converted -14.37x of net income into operating cash flow.
Macro sensitivity
Most sensitive to the broad stock market.
- the broad stock market: This stock moves with the broad market (high beta).
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates.
Management & capital allocation
Not enough signal yet.
Earnings setup & market context
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
Earnings setup · pre-print positioning
forward-looking
Neutral10 analysts, 33% Buyfor period ending 2026-06-30
Why this setup
Consensus revisions
EPS estimate $0.61 → $0.61 (+0.1% / 30d). 3 raised, 5 cut, 10 covering analysts.
Rating actions
0 upgrades, 0 downgrades / 30d, 2 maintained. 33% of analysts rate Buy.
Price target activity
1 PT revisions / 30d. Avg target 11.6% above current price.
Sector context
Intermediate · WeeklySector phase: financials is in growth, with decelerating (~3.2 years in phase).
Sector regime (90d momentum): headwind.Secular epoch: by revenue growth.Management scorecard
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Long-term · 1–3 yr
Overall: neutral
- Capital allocation
- neutral
- Earnings discipline
- weak
- Margin discipline
- neutral
- Balance sheet
- neutral
- Post-call reaction
- neutral
A guidance track record builds as the company issues and delivers on guidance.
as of 2026-06-12
How bumpy is the path
(risk while you hold it)Risk: how this stock moves
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
Intermediate · WeeklyLong-term · 1–3 yr
On a typical day, $10k can swing ±$144.
How much price usually moves either way.
On a bad day, this stock has moved -$334.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,204.
Deepest peak-to-trough drop in the last year.
moderateas of 2026-06-12
Past results, not a forecast. Not investment advice.
What would change the read
(catalysts & re-read triggers)What changed
The most important moves since the prior daily snapshot.
Short-term · Daily
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
What to watch next
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Intermediate · Weekly
- UpsideHigh confidenceQuartersactive 18d
Watch for Q2 net long-term inflows exceeding $22 billion
Why it matters: Strong inflows show demand for Invesco's products. This suggests growth potential.
What confirms / what disproves
Confirms:Q2 net long-term inflows reported above $22 billion.
Disproves:Q2 net long-term inflows fall below $20 billion.
Earnings call
News catalysts
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for IVZ yet.
This sector is also watching
- Watch for revenue growth dropping below 10% across major banks
- Watch for changes in FOMC interest rate policy on June 17
What could change this view
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Intermediate · Weekly
Upside triggers
- If sector bellwethers like BLK, BX, and KKR keep beating earnings and guiding higher, the Financials sector momentum should keep lifting IVZ and other Financials names. Worth watching these names for early signals.
- If IVZ raises forward guidance on the next earnings call (currently NEW as of 2026-04-28), that's a momentum boost. Street estimates typically follow guidance up and the stock tends to re-rate higher.
Downside triggers
- If IVZ cuts guidance on the next call (currently NEW as of 2026-04-28), that's a meaningful negative. The Street tends to walk down estimates and the stock usually takes a leg lower.
- If the Fed starts cutting rates from the current 3.62%, that would weigh on IVZ and other Financials names, since the sector usually outperforms when rates stay high.
- If sector bellwethers like BLK, BX, and KKR start missing or guiding lower, the Financials tailwind helping IVZ and other Financials names could fade. Watch these names for early warning.
Recent events
(material 8-K / filing activity)Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-281mo agoItem 2.02
Results of Operations and Financial Condition. On April 28, 2026, Invesco Ltd. (the “registrant”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026. A copy of that press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subje…
Earnings preannouncementneutral
Score history
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
+12 vs last weeklatest as of 2026-06-13
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.